Impact of a panel of 88 single nucleotide polymorphisms on the risk of breast cancer in high-risk women: results from two randomized tamoxifen prevention trials.
Authors
Cuzick, JBrentnall, A
Segal, C
Byers, H
Reuter, C
Detre, S
Lopez-Knowles, E
Sestak, I
Howell, Anthony
Powles, T
Newman, W
Dowsett, M
Affiliation
Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of LondonIssue Date
2016-12-28